awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34088194-13B3804A-5C9D-489A-8DDD-1818DE73811D
Q34088194-13B3804A-5C9D-489A-8DDD-1818DE73811D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34088194-13B3804A-5C9D-489A-8DDD-1818DE73811D
FCGR3A 158V/F polymorphism and response to frontline R-CHOP therapy in diffuse large B-cell lymphoma.
P2860
Q34088194-13B3804A-5C9D-489A-8DDD-1818DE73811D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34088194-13B3804A-5C9D-489A-8DDD-1818DE73811D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a7b67d6b4a0dda69509e45134a8540d82cf8d12
P2860
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).